| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,553 | 0,625 | 16:01 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.11. | Theraclion Obtains FDA Authorization for Sonovein, Opening a New Era in Non-invasive Vein Care in the United States | 684 | Business Wire | Sonovein becomes the first non-invasive HIFU platform to receive U.S. marketing authorization for the treatment of superficial venous reflux in Great Saphenous Vein (GSV) segments through the... ► Artikel lesen | |
| 03.11. | Theraclion Strengthens Its Growth Prospects in the Middle East by Obtaining Marketing Authorisation for Sonovein in Saudi Arabia | 394 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for the non-invasive treatment of varicose veins using high-intensity... ► Artikel lesen | |
| 28.10. | Theraclion Announces the Initiation of Coverage by TP ICAP Midcap With a Target Price of EUR 1.70, Confirming the Potential of Sonovein | 425 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 16.09. | 2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development | 712 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive treatment of varicose veins using High-Intensity... ► Artikel lesen | |
| 20.08. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 531 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 23.07. | Theraclion Initiates Its Commercial Momentum in the First Half of 2026 | 751 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 15.07. | Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL | 521 | Business Wire | Regulatory News:
Theraclion (Paris:ALTHE):
Listing venue: Euronext Growth Paris
PEA-PME eligible
ISIN Code: FR0010120402
Website: www.theraclion.com
Under the liquidity contract entrusted... ► Artikel lesen | |
| 09.07. | Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors | 567 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 02.07. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 474 | Business Wire | Article 223-16 Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 18.06. | Theraclion Announces the Evolution of Its Board of Directors | 994 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 08.06. | Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein With AMA CPT Editorial Panel Approval of a New Category III CPT Code | 605 | Business Wire | Regulatory News:
Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment... ► Artikel lesen | |
| 04.06. | Theraclion Announces First Clinical Deployment of Sonovein in Hainan, China | 658 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402 Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the... ► Artikel lesen | |
| 03.06. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 462 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 01.06. | Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented | 517 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse
Theraclion... ► Artikel lesen | |
| 11.05. | Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase | 574 | Business Wire | Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million
Regulatory News:
This press release and the information it contains... ► Artikel lesen | |
| 23.04. | XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026 | 791 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026
Aktien
1 ID1000132806 PT Multi Bintang Indonesia... ► Artikel lesen | |
| 20.04. | Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription... | 959 | Business Wire | Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical... ► Artikel lesen | |
| 16.04. | Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook | 802 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.01. | Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up | 640 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 09.12.25 | Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements | 945 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 31,340 | +0,90 % | Spritzgießfertigung: Gerresheimer plant mit APS-Software | ||
| MCKESSON | 995,20 | -1,02 % | McKesson Corp. Profit Advances In Q2 | WASHINGTON (dpa-AFX) - McKesson Corp. (MCK) announced earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $1.218 billion, or $10.47 per share. This... ► Artikel lesen | |
| INMODE | 11,805 | -1,34 % | InMode Ltd.: InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial Outlook | YOKNEAM, Israel, Nov. 11, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
| HCA HEALTHCARE | 462,00 | -0,56 % | Nach der US-Wahl: Diese Aktien werden jetzt zu Gewinnern - deutsche Konzerne dabei | © Foto: wO-GeminiDer Wahlsieg der Demokraten verändert die Spielregeln an der Börse. Solaraktien schießen nach oben, auch Europas Industrie hofft auf Entlastung. Welche Unternehmen kurz- und langfristig... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 590,00 | 0,00 % | Aktien KW 36 Iran, Zinsangst und Trump-"unsinn" bremsen - was wäre wenn? News. Rheinmetall. Vonovia. DEFAMA. Smartbroker. Sino. Trade Republic. Limes Schlosskliniken. Mutares. Symrise. Aroundtown. Enapter. Bilfinger. Nagarro. Haier Smart. Delivery Hero | Aktien - diese Woche im Niemandsland. Positiv am Ende der Woche steht wieder 26 am Anafng des DAX, aber Schwung nach oben fehlt. Impulse hätten Nvidia und die anderen Ki-Aktien mit teilweise beeindruckenden... ► Artikel lesen | |
| BEYOND AIR | 2,040 | +2,00 % | Morning Market Movers: Phaos Technology, Cardinal Infrastructure Group, Addentax Group, Beyond Air See Big Swings | SANTA CLARA (dpa-AFX) - At 7:15 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 22,200 | -1,77 % | HEALTHCARE SERVICES GROUP INC - 10-Q, Quarterly Report | ||
| ADDUS HOMECARE | 111,00 | +0,91 % | RBC Capital raises Addus HomeCare stock price target on platform momentum | ||
| INTERPACE BIOSCIENCES | - | - | Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M | ||
| MODERN DENTAL | 0,815 | +1,24 % | Modern Dental Group Limited: CICC Initiates Coverage of Modern Dental Group (03600.HK) with Outperform Rating and Target Price of HK$10.0: Accelerating Global Expansion with Digital Efficiency | HONG KONG, Oct 12, 2026 - (ACN Newswire) - CICC initiates coverage on Modern Dental Group (03600.HK) with an 'Outperform' rating and a target price of HK$10.00, highlighting three key drivers. 1) Digitalization-led... ► Artikel lesen | |
| MYOMO | 0,937 | -0,53 % | Myomo narrows 2026 revenue guidance to $46M-$47M as it expects modest sequential gross margin improvement in Q4 | ||
| IVF HARTMANN | 133,00 | 0,00 % | IVF Hartmann erwirtschaftet im Halbjahr klar mehr Umsatz | Neuhausen am Rheinfall - Der Medizinalbedarf-Hersteller IVF Hartmann hat im ersten Halbjahr 2026 den Umsatz zweistellig gesteigert. Der Gewinn nahm im Vergleich dazu noch deutlicher zu. Die Prognose... ► Artikel lesen | |
| ICU MEDICAL | 164,00 | 0,00 % | Biotech Stocks At 52-Week Highs - Anika Therapeutics & Chemed Corporation Rise With Q2 Results, ICU Medical, Neurocrine Biosciences, Royalty Pharma | LONDON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 29, 2026, driven by key catalysts such as the release of second quarter financial results and ongoing clinical... ► Artikel lesen | |
| FRESENIUS | 53,65 | -0,39 % | Aktien Frankfurt: Dax-Gewinn schmilzt nach Anstieg über 27.000 Punkte zusammen | FRANKFURT (dpa-AFX) - Der Höhenflug des Dax ist am Donnerstag im Handelsverlauf deutlich ausgebremst worden. Händler verwiesen auf Äußerungen von US-Präsident Donald Trump zum Iran-Krieg als Belastung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,220 | -1,77 % | Siemens-Aktie: Wie viel Luft hat die Dividende nach dem Healthineers-Abschied? | Siemens als Dividendenwert? Mit knapp 2 Prozent Rendite wirkt der Konzern eher wie ein Wachstumswert im Anzug. Doch die Ausschüttung klettert Jahr für Jahr, und jetzt trennt sich Siemens auch noch von... ► Artikel lesen |